🇺🇸 Eldecalcitol capsules in United States

12 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 12

Most-reported reactions

1. Herpes Zoster — 2 reports (16.67%)
2. Immunosuppression — 2 reports (16.67%)
3. Adrenocorticotropic Hormone Deficiency — 1 report (8.33%)
4. Anorectal Disorder — 1 report (8.33%)
5. Bladder Disorder — 1 report (8.33%)
6. Blood Pressure Increased — 1 report (8.33%)
7. Decreased Appetite — 1 report (8.33%)
8. Diabetic Ketoacidosis — 1 report (8.33%)
9. Dyschezia — 1 report (8.33%)
10. Dyspnoea — 1 report (8.33%)

Source database →

Frequently asked questions

Is Eldecalcitol capsules approved in United States?

Eldecalcitol capsules does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Eldecalcitol capsules in United States?

Shanghai Jiao Tong University Affiliated Sixth People's Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.